Accordingly, global profiling of Pten+/− TRAP1 transgenic mice by RNA sequencing and reverse phase protein array modulated oncogenic networks of cell proliferation, apoptosis, cell motility and DNA damage [41], further supporting the role of TRAP1 as a driver of prostate cancer, with potential for novel therapeutic approaches. This evidence concerns the gene PTEN and prostate cancer.